Recruiting Kidney Cancer Studies in Baltimore
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
This is a phase 3, open label, single arm study of padeliporfin in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade non-invasive upper...
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (c...
About Kidney Cancer Clinical Trials in Baltimore
Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.
There are currently 2 kidney cancer clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 143 participants. Research is being sponsored by Steba Biotech S.A., Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Kidney Cancer Clinical Trials in Baltimore — FAQ
Are there kidney cancer clinical trials in Baltimore?
Yes, there are 2 kidney cancer clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What kidney cancer treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.
Data updated March 2, 2026 from ClinicalTrials.gov